Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3414636
Max Phase: Preclinical
Molecular Formula: C42H58N8O12
Molecular Weight: 866.97
Molecule Type: Small molecule
Associated Items:
ID: ALA3414636
Max Phase: Preclinical
Molecular Formula: C42H58N8O12
Molecular Weight: 866.97
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)[C@H](CCCNC(=N)N)NC(=O)COc1cc2oc3cc(OCC(=O)N[C@@H](CCCNC(=N)N)C(=O)OC)c(OC)c(CC=C(C)C)c3c(=O)c2c(O)c1CC=C(C)C
Standard InChI: InChI=1S/C42H58N8O12/c1-22(2)12-14-24-28(60-20-32(51)49-26(39(55)58-6)10-8-16-47-41(43)44)18-30-35(36(24)53)37(54)34-25(15-13-23(3)4)38(57-5)31(19-29(34)62-30)61-21-33(52)50-27(40(56)59-7)11-9-17-48-42(45)46/h12-13,18-19,26-27,53H,8-11,14-17,20-21H2,1-7H3,(H,49,51)(H,50,52)(H4,43,44,47)(H4,45,46,48)/t26-,27-/m0/s1
Standard InChI Key: IFZYKAZYHUCYHJ-SVBPBHIXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 866.97 | Molecular Weight (Monoisotopic): 866.4174 | AlogP: 2.28 | #Rotatable Bonds: 23 |
Polar Surface Area: 312.73 | Molecular Species: BASE | HBA: 14 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 8.13 | CX Basic pKa: 12.46 | CX LogP: 1.39 | CX LogD: -0.75 |
Aromatic Rings: 3 | Heavy Atoms: 62 | QED Weighted: 0.02 | Np Likeness Score: 0.76 |
1. Koh JJ, Lin S, Aung TT, Lim F, Zou H, Bai Y, Li J, Lin H, Pang LM, Koh WL, Salleh SM, Lakshminarayanan R, Zhou L, Qiu S, Pervushin K, Verma C, Tan DT, Cao D, Liu S, Beuerman RW.. (2015) Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections., 58 (2): [PMID:25474410] [10.1021/jm501285x] |
2. Lin S, Sin WLW, Koh JJ, Lim F, Wang L, Cao D, Beuerman RW, Ren L, Liu S.. (2017) Semisynthesis and Biological Evaluation of Xanthone Amphiphilics as Selective, Highly Potent Antifungal Agents to Combat Fungal Resistance., 60 (24): [PMID:29155590] [10.1021/acs.jmedchem.7b01348] |
3. Lin S, Koh JJ, Aung TT, Lim F, Li J, Zou H, Wang L, Lakshminarayanan R, Verma C, Wang Y, Tan DT, Cao D, Beuerman RW, Ren L, Liu S.. (2017) Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity., 60 (4): [PMID:28122182] [10.1021/acs.jmedchem.6b01403] |
Source(1):